Clear

Los Angeles, CA

21°C

Clear

Humidity: 59%

Wind: W at 5 mph

World News

More in: Inspiring Discoveries, Beyond Science, Space & Astronomy, Earth and the Environment, Real Estate, Global Markets, Economy & Trade, Companies, Asia, USA, Africa, Europe, International
next
prev

Medicine

Cancer death rate in EU is expected to fall in 2012

Friday, 02 March 2012 00:03
Written by Navid Iqbal
Print PDF

After studying World Health Organization data researchers say that the number of deaths caused by cancer should go down by almost 7% and 6% respectively in men and women. The data were compared with 2007 death rates.

It is estimated that about 1.3 million cancer patient will die in Europe this year.

According to a journal named ‘Annals of Oncology’ the low down in stomach cancer, breast cancer, male lung cancer and womb cancer and other cases will continue.

But lung cancer in women is on the rise all over the EU except UK. Although in this case for almost a decade UK holds the highest rate. Now the rate is not dropping but settling down.

Carlo La Vecchia, a professor from Milan University along with Professor Fabio Levi at Lausanne University have reached a conclusion calculating the general rate of cancer in Europe and also separate rates of six vital countries in Europe.

This overall downswing in cancer death rates is caused by the decline in mortality rate involving a few types of cancers.

In an analysis it shows that number of death from breast cancer should fall by at least 9% in 2012.

Lung cancer and colorectal cancer in men are also showing major decline.

But when it comes to lung cancer, women certainly can’t be happy. In 2007 in per 100,000 the number of death was 12.55. But in 2011 it has gone up to 13.12.

But good news for women is that the increased death rate caused by pancreatic cancer in women is leveling off.

From ‘British Lung Foundation’ Professor Stephen Spiro says that lung cancer is still in general responsible for the biggest numbers of death.

When it comes to men, in the last 3 decades lung cancer death rate has significantly dropped. Because a large number of men already have and intending to quit smoking.

But it is a completely different picture with women. Today approximately one quarter of them smoke regularly.

Mike Hobday, working at the ‘Macmillan Cancer Support’ as chief of policy happily greeted the reduction in cancer death rates. He also warned about the number of cancer patients in UK is going up by 3% each year.

He added, in UK there is about 2 million people under cancer diagnosis. And if the list goes up in this rate, UK will have to handle at least 4 million cancer patients by the year of 2030.

Sleep Apnea Has Strong Link With Silent strokes

Thursday, 02 February 2012 19:04
Written by Navid Iqbal
Print PDF

 

In the last week, an analysis was presented in “International Stroke Conference” of the “American Stroke Association”.  That was a little study what adds the further proof to what the most of sleep experts know already - that “Obstructive sleep apnea” or OSA is actually linked with the high level of risk of getting the silent strokes.

OSA or Obstructive Sleep Apnea is very much common appearance of the sleep apnea, in line with the organization of “National Institutes of Health”.  In excess of twelve million Americans now are believed in suffering from this type of sleep disorder. Many of the people with the sleep apnea generally stop breathing just for ten  to twenty  seconds or else longer than that and it  can cause in any case twenty  to thirty times in one hour.

In the new study, the researchers at the Dresden University which is in Germany, normally looked at the silent strokes as well as the occurrence of the OSA in fifty six patients who actually had been then hospitalized for the major stroke. Now, what is the major difference between this kind of stroke and the silent stroke?  Usually the silent strokes are detected only by imaging brain with the  MRI or/and CT scan what can show the areas of that damage even if the attacked person was actually not that much aware of the obvious neurological shortfall at that time of scarring.

The silent stroke has been linked with the increase risk just for the major stroke. As a result, if people can establish in addition to eliminate all the risk factors only for the silent stroke, hypothetically, all of the people can avoid the risk of having major strokes what can kill as well as disable. Moreover, the stroke victim in that study was then broken into the two groups: People of those who actually had the confirmation of the silent strokes plus those who normally did not.  Then they also looked at all those victims who had the evidence of the chronic damages to the little blood vessel in brain plus those who actually did not.  The researchers actually tried to observe if the OSA was common in those people with the silent stroke as well as with the chronic vascular break. 91%   of the patients of the study had the OSA or obstructive sleep apnea, this was identified by the test on overnight sleep.

 

A Type of Protein Can Help on Dealing with Cancer – CPE-delta N

Tuesday, 01 February 2011 18:21
Written by Julius
Print PDF

Scientists recently reported that high levels of a certain protein in cancer may indicate which particular tumors are likely to multiply and spread. This was revealed as a result of a new study of medicine and clinical investigation which showed that high levels of CPE-delta N (a form of protein) predicted with sharp accuracy whether a tumor moved on from its previous location in the body of patients diagnosed with liver cancer (and adrenal cancer). The accuracy was rated at ninety percent. This late development may hold the key to improving detection of cancer in people’s bodies.

As such, further testing on CPE-delta N will be conducted and it remains to be seen if in the years to come scientists will eventually be able to come up with ways to determine if tumors spread and even predict whether the tumor will recur in the same tissue or in other parts of the person’s body. As of this stage, there is no accurate way of determining such developments. Currently, doctors use the grade and stage of a tumor to find out the prognosis of a patient.

The recent development of the CPE-delta N’s ability to predict tumor movement has baffled or intrigued some members of the health and scientific community. Around the world there are groups of researchers who took samples from the bodies of cancer patients as well as patients diagnosed with pheochromocytoma (adrenal gland tumor) and continue to do studies in search of breakthroughs. It remains to be seen how long the studies will take.